Login / Signup

Dauricine Inhibits Non-small Cell Lung Cancer Development by Regulating PTEN/AKT/mTOR and Ras/MEK1/2/ERK1/2 Pathways in a FLT4-dependent Manner.

Jinna LiangPanpan LeiXinyue SuJiapan GaoBingxi RenYuxiu ZhangXiaoyu MaWeina Ma
Published in: Current cancer drug targets (2024)
Dauricine may be a promising FLT4 inhibitor for the treatment of NSCLC.
Keyphrases
  • cell proliferation
  • pi k akt
  • acute myeloid leukemia
  • signaling pathway
  • tyrosine kinase
  • small cell lung cancer
  • advanced non small cell lung cancer
  • combination therapy
  • brain metastases